PD-1 signaling also prevents the conversion of CD8+ central memory T cells (TCM) into CD8+ effector memory T cells (TEM) [79], reducing the long-term immune memory that may prevent future metastatic diseases. This evidence concerns the gene CD8A and metastatic neoplasm.